Armata Pharmaceuticals Inc (ARMP)

1.95 -0.03 (-1.52%) USD  |  NYAM  |  Dec 20, 16:00
1.90 -0.05 (-2.56%) After-Hours: 20:00
More

Armata Pharmaceuticals Enterprise Value: 160.82M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for ARMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AIM ImmunoTech Inc 7.634M
Perspective Therapeutics Inc -73.53M
Protalix BioTherapeutics Inc 102.19M
Electromed Inc 220.68M
Xtant Medical Holdings Inc 78.22M

Enterprise Value Related Metrics

Net Income (Quarterly) -5.481M
Total Expenses (Quarterly) 9.756M
EPS Diluted (Quarterly) -0.15
Earnings Yield -84.10%
Normalized Earnings Yield -2161.09